Growth in the presence of salicylate increases fluoroquinolone resistance in Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 4, 1999, Pages 990-992

  Gustafson, John E ^a   Candelaria, Pierre V ^a   Fisher, Scott A ^a   Goodridge, Jodie P ^a   Lichocik, Tanya M ^a   Mcwilliams, Tracy M ^a   Price, Christopher T D ^a   O'Brien, Frances G ^a   Grubb, Warren B ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CIPROFLOXACIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SALICYLIC ACID;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL MUTATION; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM ISOLATE; CELL DEATH; CELL SURVIVAL; DRUG EFFECT; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0032919759     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.4.990     Document Type: Article

References (21)

1. Alekshun, M. N., and S. B. Levy. 1997. Regulation of chromosomally mediated multiple resistance: the mar regulon. Antimicrob. Agents Chemother. 41:2067-2075.
2. Axon, J. M. C., and E. C. Huskisson. 1992. Use of aspirin in inflammatory diseases, p. 295-320. In J. R. Vane and R. M. Botting (ed.), Aspirin and other salicylates. Chapman & Hall, London, England.
3. Berger-Bächi, B., A. Strässle, J. E. Gustafson, and F. H. Kayser. 1992. Mapping and characterization of multiple chromosomal factors involved in methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 36:1367-1373.
4. Burns, J. L., and D. K. Clark. 1992. Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein. Antimicrob. Agents Chemother. 36:2280-2285.
5. Chambers, H. F. 1988. Methicillin-resistant staphylococci. Clin. Microbiol. Rev. 1:173-186.
6. Cohen, S. P., H. Hächler, and S. B. Levy. 1993. Genetic and functional analysis of the multiple-antibiotic-resistance (mar) locus in Escherichia coli. J. Bacteriol. 175:1484-1492.
7. Cohen, S. P., S. B. Levy, J. Foulds, and J. L. Rosner. 1993. Salicylate induction of antibiotic resistance in Escherichia coli: activation of the mar operon and a mar-independent pathway. J. Bacteriol. 175:7856-7862.
8. Domenico, P., T. Hopkins, and B. A. Cunha. 1990. The effect of sodium salicylate on antibiotic susceptibility and synergy in Klebsiella pneumoniae. J. Antimicrob. Chemother. 25:343-351.
9. Ferrero, L., B. Cameron, B. Manse, D. Lagneaux, J. Crouzet, A. Famechon, and F. Blanche. 1994. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones. Mol. Microbiol. 13:641-653.
10. Goldman, J. D., D. G. White, and S. B. Levy. 1996. Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones. Antimicrob. Agents Chemother. 40:1266-1269.
11. Hiramatsu, K., N. Aritaka, H. Hanaki, S. Kawasaki, Y. Hosoda, S. Hori, Y. Fukuchi, and I. Kobayashi. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670-1673.
12. Ito, H., H. Yoshida, M. Bogaki-Shonai, T. Niga, H. Hattori, and S. Nakamura. 1994. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus. Antimicrob. Agents Chemother. 38: 2014-2023.
13. Neu, H. C. 1983. Ciprofloxacin: an overview and prospective appraisal. Am. J. Med. 83(Suppl. 4A):395-404.
14. Ng, E. Y. W., M. Trucksis, and D. H. Hooper. 1994. Quinolone resistance mediated by norA: physiological characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome. Antimicrob. Agents Chemother. 38:1345-1355.
15. Ng, E. Y. W., M. Truckis, and D. C. Hooper. 1996. Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus. Antimicrob. Agents Chemother. 40:1881-1888.
16. O'Brien, F. G., C. I. Botterill, T. G. Endersby, R. L. G. Lim, W. B. Grubb, and J. E. Gustafson. 1998. Heterogeneous expression of fusidic acid resistance in Staphylococcus aureus with plasmid or chromosomally encoded fusidic acid resistance genes. Pathology 30:299-303.
17. Ohshita, Y., K. Hiramtsu, and T. Yokota. 1990. A point mutation in norA gene is responsible for quinolone resistance in Staphylococcus aureus. Biochem. Biophys. Res. Commun. 172:1029-1034.
18. Okusu, H., D. Ma, and H. Nikaido. 1996. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J. Bacteriol. 178:306-308.
19. Sumita, Y., and M. Fukasawa. 1993. Transient carbapenem resistance induced by salicylate in Pseudomonas aeruginosa associated with suppression of outer membrane protein D2 synthesis. Antimicrob. Agents Chemother. 37: 2743-2746.
20. Szybalski, W., and V. Bryson. 1952. Genetic studies on microbial cross resistance to toxic agents. I. Cross resistance of Escherichia coli to fifteen antibiotics. J. Bacteriol. 64:489-499.
21. Udo, E. E., I. A. Al-Obaid, L. E. Jacob, and T. D. Chugh. 1996. Molecular characterization of epidemic ciprofloxacin- and methicillin-resistant Staphylococcus aureus strains colonizing patients in an intensive care unit. J. Clin. Microbiol. 34:3242-3244.